Access cutting-edge breast cancer treatment through this clinical trial at a research site in Highlands Ranch. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Highlands Ranch at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in participants with hormone receptor positive/human epidermal growth factor receptor-2 negative (HR+/HER2-) unresectable locally advanced, or metastatic, breast cancer. The primary hypotheses are that sacituzumab tirumotecan as a single agent and sacituzumab tirumotecan plus pembrolizumab are superior to TPC with respect to progr
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this breast cancer clinical trial in Highlands Ranch, CO
If you're searching for breast cancer treatment options in Highlands Ranch, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Highlands Ranch research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.